Antiplatelet therapy in peripheral arterial disease

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 4, Issue 3, 2004, Pages 265-267

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Aspirin; Clopidogrel; Dipyridamole; Peripheral arterial disease; Ticlodipine

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; BERAPROST; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; PROSTACYCLIN DERIVATIVE; THROMBOXANE A2; TICLOPIDINE;

ANGIOPLASTY; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL GRAFT; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG MECHANISM; HEART INFARCTION; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; MORTALITY; PERIPHERAL VASCULAR DISEASE; REVIEW; RISK REDUCTION; SIDE EFFECT; STROKE; TRANSIENT ISCHEMIC ATTACK;

ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; DIPYRIDAMOLE; HUMANS; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 4444338622     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043336104     Document Type: Review

References (18)

1. Aronow, W.S. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease. Drugs & Aging, 1999, 15(2): 91-101.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analyis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ., 2002, 324, 71-86.
3. De Schryver, E.L., Algra, A., van Gijn, J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst. Rev., 2003, (1):CD001820.
4. Chew, D.P., Bhatt, D.L., Sapp, S., Topol, E.J. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists. A meta-analysis of phase III multicenter randomized trials. Circulation, 2001, 103: 201-206.
5. Mohler, E.R. III, Hiatt, W.R., Olin, J.W. et al. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial. J. Am. Coll. Cardiol., 2003, 41: 1679-1686.
6. Roth, G.J., Majerus, P.W. The mechanism of the effect of aspirin on human platelets: I. Acetylation of a particulate fraction protein. J. Clin. Invest., 1975, 56, 624-632.
7. Hess, H., Mietaschk, A., Deichsel, G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. Lancet, 1985, 1, 415-419.
8. Giansante, C., Calabrese, S., Fisicaro, M., et al. Treatment of intermittent claudication with antiplatelet agents. J. Int. Med. Res., 1990, 18, 400-407.
9. Goldhaber, S.Z., Manson, J.E., Stampfer, M.J., et al. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study. Lancet, 1992, 340, 143-145.
10. Ranke, C., Hecker, H., Creutzig, A., et al. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation, 1993, 87, 1873-1879.
11. Jackson, M.R., Clagett, G.P. Antithrombotic therapy in peripheral arterial occlusive disease. Chest, 2001, 119, 283S-299S.
12. Hardisty, R.M., Powling, M.J., Nokes, T.J. The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins. Thromb. Haemost., 1990, 64, 145-150.
13. Janzon, L., Bergqvist, D., Boberg, J., et al. Prevention of myocardial infarction and stroke in patients with intermittent claudication: effects of ticlodipine. Results from STIMS, the Swedish Ticlodipine Multicentre Study. J. Intern. Med., 1990, 227, 301-308.
14. Arcan, J.C., Blanchard, J., Boissel, J.P., et al. Multicenter double-blind study of ticlodipine in the treatment of intermittent claudication and the prevention of its complications. Angiology, 1988, 39, 802-811.
15. Blanchard, J., Carreras, .LO., Kindermans, M. Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlodipine in patients with peripheral arterial disease. Nouv. Rev. Fr. Hematol., 1993, 35, 523-528.
16. Bennett, C.L., Weinberg, P.D., Rozenberg-Ben-Dror, K., et al. Thrombotic thrombocytopenic purpura associated with ticlopidine; a review of 60 cases. Ann. Intern. Med., 1998, 128, 541-544.
17. Mills, D.C., Puri, R., Hu, C.J., et al. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb., 1992, 12, 430-436.
18. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996, 348, 1329-1339.